Today, the drug development industry is betting heavily on precision medicine. Leading pharma/biopharma companies have nearly doubled their investment in personalized medicines in the last 5 years, and expect an additional 1/3 increase over the next 5 years.

from Forbes – Tech http://ift.tt/2n63f9V
via IFTTT